Literature DB >> 19908314

Validation of self-report depression rating scales in Huntington's disease.

Jennifer De Souza1, Lisa A Jones, Hugh Rickards.   

Abstract

The aim of this study was to assess the criterion validity of three self-report measures of depression in a sample of patients with Huntington's disease (HD). Fifty patients with HD completed the Beck Depression Inventory-II (BDI-II), the Hospital Anxiety and Depression Scale (HADS), and the Depression Intensity Scale Circles (DISCs). Current psychiatric status was assessed using the schedules for clinical assessment in neuropsychiatry (SCAN), and ICD-10 diagnosis was used as the gold standard. Receiver operating characteristics (ROC) curves were obtained and the sensitivity, specificity, positive, and negative predictive values were calculated for different cut-off scores on each rating scale. Twelve patients (24%) met ICD-10 criteria for depressive disorder. The depression sub-scale of the HADS (HADS-D) at an optimal cut-off of 6/7 was found to discriminate maximally between depressed and nondepressed patients in this population. The DISCs at a cut-off of 1/2 also performed well at detecting possible "cases" of depression, whereas the BDI-II performed the least satisfactorily of all scales. The HADS-D and DISCs are good screening measures for depression in the HD population and the DISCs may be particularly useful in those patients with more severe communicative and cognitive deficits.

Entities:  

Mesh:

Year:  2010        PMID: 19908314     DOI: 10.1002/mds.22837

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes.

Authors:  Gloria M Reeves; Kelly J Rohan; Patricia Langenberg; Soren Snitker; Teodor T Postolache
Journal:  J Affect Disord       Date:  2012-01-25       Impact factor: 4.839

2.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

3.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

4.  Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia.

Authors:  Abhilasha Surampalli; Manaswitha Khare; Georgette Kubrussi; Marie Wencel; Jasmin Tanaja; Sandra Donkervoort; Kathryn Osann; Mariella Simon; Douglas Wallace; Charles Smith; Aideen M McInerney-Leo; Virginia Kimonis
Journal:  J Genet Couns       Date:  2015-02-26       Impact factor: 2.537

5.  [Predictors of mental and physical quality of life in Huntington's disease].

Authors:  F Brugger; C Hepperger; E-M Hametner; A K Holl; A Painold; C Schusterschitz; R Bonelli; C Holas; G K Wenning; W Poewe; K Seppi
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

6.  Clinical and genetic investigation of a Brazilian family with Huntington's disease.

Authors:  L A Agostinho; M Spitz; J S Pereira; C L A Paiva
Journal:  Funct Neurol       Date:  2016 Jul-Sep

Review 7.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

8.  Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.

Authors:  Ji-in Kim; Jeffrey D Long; James A Mills; Elizabeth McCusker; Jane S Paulsen
Journal:  Neuropsychology       Date:  2015-05-25       Impact factor: 3.295

9.  Locus of control in patients with Huntington disease: a cross-sectional study.

Authors:  Brynne E Stainsby; Silvano Mior; Mark Guttman
Journal:  J Can Chiropr Assoc       Date:  2020-04

10.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.